PRIME North America Vol.5 Issue 6

INDUSTRY INSIDER | SINCLAIR PHARMA | 20 November/December 2017 | prime-journal.com Fueledbystrongpatient demand, Silhouette InstaLift™ is fillinganunmet need inaestheticpractitioners’ treatment toolbox WENDY LEWIS is President of Wendy Lewis & Co Ltd, Global Aesthetics Consultancy, author of 11 books, and Founder/ Editor-in-Chief of www. beautyinthebag.com . She is a contributor to a number of trade and consumer publications in the USA and Europe. contact wl@wlbeauty.com A S FACIAL REJUVENATIONMETHODS have evolved, suture lifts have gained popularity among patients who are seeking a non-surgical minimally invasive alternative to a traditional facelift procedure. But not all sutures are the same, and Sinclair Pharma is trying to turn around some misconceptions about this emerging category of minimally invasive options. In 2016, under the direction of CEO Chris Spooner, London-based Sinclair Pharma Plc was transformed into a streamlined, pure-play aesthetics company with a concentrated, competitive portfolio of differentiated injectable products. ‘We recognized that effective, longer- lasting, natural looking, minimally invasive treatments are skyrocketing in popularity, largely driven by the global trend of consumers moving away from intensive plastic surgery and the USmarket represented amajor growth opportunity for demand for Silhouette InstaLift™, says Mr. Spooner. After divesting their pharma portfolio, Sinclair has emerged as a powerhouse in the aesthetics market with a focused portfolio of products that deliver natural-looking and minimally-invasive treatments. Sinclair is a global company that provides best-in-class products for safe and effective rejuvenation solutions, which is considered the sweet spot by aesthetic practitioners. Their current brands include the Silhouette Soft® range of sutures, and dermal fillers Ellanse® and Perfectha®, and they also maintain the rights to distribute Sculptra® Aesthetic in 19 countries including the UK*. Oneofthecompany’scoreprinciplesistheircommitment to support medical professionals with high-quality training programs. Thus, in 2016, Sinclair partnered with ThermiGen® in Dallas to market Silhouette InstaLift in the US. Thermi®, an Almirall Company, is a leading global manufacturer of temperature controlled radiofrequency technology. The company’s flagship product is ThermiRF®, a platform technology that uses temperature as an endpoint, and an array of minimally and non-invasive applications, including ThermiTight®, ThermiRase®, ThermiSmooth® Face, ThermiVa®, and the Thermi250™ device for the body. The Sinclair strategy was to train and educate leading dermatologists and plastic surgeons across the US to create demand for this non-invasive treatment that filledanunmet need. To date, the Sinclair-Thermi team has trained more than 1,000practitioners throughCMEprograms at local and national meetings across the country, and the interest among physicians continues to expand. ‘In-market demand for Silhouette InstaLift in the US is strong and has been steadily growing since our launch. Silhouette InstaLift is the only facial rejuvenation Sinclair is a global company that provides best-in-class products for safe and effective rejuvenation solutions, which is considered the sweet spot by aesthetic practitioners. NEXT GENERATION SUTURE SUSPENSIONLIFTS ARE PICKINGUP STEAM INTHEU.S.

RkJQdWJsaXNoZXIy MTA4OTE=